| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Apr―24 |
Impact of Remdesivir on Heart Rate and Bradycardia Incidence Among Hospitalized Adults With COVID-19 |
Wesley D. Kufel, Zoey J. Zagoria, Robert W. Seabury, Nabil Zeineddine, Stephen J. Thomas, Sarah A. Spinler, Jeffrey M. Steele |
| 2 |
[GO] |
2024―Sep―09 |
Comment on: Increased Theophylline Plasma Concentrations in a Patient With COVID-19 |
Evelyn Krohmer, Walter E. Haefeli |
| 3 |
[GO] |
2024―Mrz―27 |
Increased Theophylline Plasma Concentrations in a Patient With Covid-19 |
Miriam Rodríguez Fernández, Ana Concepción Sánchez Cerviño, Ana Codonal Demetrio, Nagore Lois Martínez, Benito García Díaz |
| 4 |
[GO] |
2024―Jan―30 |
Monoclonal Antibody Infusions for Outpatient Management of Mild-Moderate COVID-19 |
Hannah B. Knox, Lisa A. Dykes, Lancer A. Scott, Bradley C. Presley, Lara C. Lambert |
| 5 |
[GO] |
2023―Nov―28 |
Efficacy of Fluvoxamine in Outpatients With COVID-19: Understanding Conflicting Conclusions From 2 Recent Meta-Analyses of the Same Clinical Trials |
Marina Sánchez-Rico, Katayoun Rezaei, Eric J. Lenze, Frédéric Limosin, Nicolas Hoertel |
| 6 |
[GO] |
2023―Sep―07 |
Intranasal Theophylline: Potential Treatment for Long COVID Olfactory Dysfunction? |
Olga Hilas, Tina Caliendo |
| 7 |
[GO] |
2023―Jul―31 |
Dosing and Administration Strategies of Tocilizumab in Patients With COVID-19: A Retrospective Cohort Analysis |
Taylor D. Steuber, Thomas Rosandich, Tiffany Cadwallader, Lauren Steil, Madeline Belk, Usha Yendrapalli, et al. (+2) Ali Hassoun, Jonathan Edwards |
| 8 |
[GO] |
2023―Mai―05 |
Adverse Events of SARS-CoV-2 Therapy: A Pharmacovigilance Study of the FAERS Database |
Viraaj Pannu, Ndausung Udongwo, Steven Imburgio, Anmol Johal, Anton Mararenko, Helen Pozdniakova, et al. (+7) Tasnuva Amin, Swapnil Patel, Mohammad Hossain, Arman Mushtaq, Edward Liu, Jose M. Fune, Joseph Heaton |
| 9 |
[GO] |
2023―Apr―06 |
Comparison of COVID-19 Vaccination and Infection Rates in Adult Patients With Autoimmune Inflammatory Disease on b/tsDMARD Therapy |
Viktoriya Avlasevich, Katharine McCarthy |
| 10 |
[GO] |
2023―Apr―01 |
Efficacy and Safety of Fluvoxamine as Outpatient Treatment for Patients With Covid-19: A Systematic Review and Meta-analysis of Clinical Trials |
Akhil Deepak Vatvani, Andree Kurniawan, Timotius Ivan Hariyanto |
| 11 |
[GO] |
2023―Apr―01 |
Risk of Thrombosis With the Use of Tocilizumab in Patients With COVID-19 |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan |
| 12 |
[GO] |
2023―Feb―27 |
A Review of the Data Supporting Use of COVID-19 Vaccinations in the Pediatric Population |
Jeremy S. Stultz, Lea S. Eiland |
| 13 |
[GO] |
2023―Jan―14 |
Comparison of Sedation and Analgesia Requirements in Patients With SARS-CoV-2 Versus Non-SARS-CoV-2 Acute Respiratory Distress Syndrome on Veno-Venous ECMO |
Mariah I. Sigala, Diane Dreucean, Jesse E. Harris, Kevin R. Donahue, Fariedeh Bostan, Prakruthi Voore, et al. (+2) Jose Cuevas, Celia Morton |
| 14 |
[GO] |
2022―Dez―28 |
Reply: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19 |
Temeka Dawn Lewis-Wolfson, Kayla Rena Joyner |
| 15 |
[GO] |
2022―Dez―28 |
Comment: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19 |
Rujittika, PhD Mungmunpuntipantip, Viroj, MD Wiwanitkit |
| 16 |
[GO] |
2022―Nov―14 |
Proportion of Patients on Warfarin Therapy Who Are Eligible for Conversion to a Direct Oral Anticoagulant in the Setting of COVID-19 |
Rachel Hess, Elizabeth Renner, Erin Mouland, Denise Sutter-Long, Nghi Ha |
| 17 |
[GO] |
2022―Okt―29 |
Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19 |
Nancy Kierstin Reid, Kayla Rena Joyner, Temeka Dawn Lewis-Wolfson |
| 18 |
[GO] |
2022―Okt―29 |
Effect of Antidiabetic Therapy on Clinical Outcomes of COVID-19 Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis |
Kegang Zhan, Liuqi Weng, Li Qi, Luhan Wang, Hao Lin, Xiaoyu Fang, et al. (+2) Hong Jia, Xiangyu Ma |
| 19 |
[GO] |
2022―Okt―08 |
Fatal COVID-19 Pneumonia in a Rheumatoid Arthritis Patient Receiving Long-Term Rituximab Therapy |
Chrong-Reen Wang, Wei-Chieh Lin |
| 20 |
[GO] |
2022―Aug―09 |
Effectiveness and Safety of Enoxaparin Versus Unfractionated Heparin as Thromboprophylaxis in Hospitalized COVID-19 Patients: Real-World Evidence |
Lina H. AlLehaibi, Mukhtar Alomar, Abdulaziz Almulhim, Sarah Al-Makki, Nazar R. Alrwaili, Shahad Al-Bassam, et al. (+5) Semat Alsultan, Jenan Al Saeed, Mohammad Alsheef, Ivo Abraham, Ahmad Alamer |
| 21 |
[GO] |
2022―Mai―20 |
The Use of High-Dose Corticosteroids Versus Low-Dose Corticosteroids With and Without Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome |
Alyson Katz, Diana Altshuler, John Papadopoulos, Nancy Amoroso, Ronald Goldenberg, Elizabeth Tarras, et al. (+6) Kelsey Krolikowski, Jacklyn Hagedorn, David Fridman, Xian Jie Cindy Chen, Eduardo Iturrate, Shari B. Brosnahan |
| 22 |
[GO] |
2022―Mai―19 |
Successful Desensitization to Remdesivir Hypersensitivity in a Patient Undergoing Treatment for COVID-19 |
Da Woon Sim, Eun Myoung, Son Hoyoung |
| 23 |
[GO] |
2022―Mai―02 |
Two Years of the COVID-19 Pandemic: What Lessons Have We Learned? |
Shannon Inglet |
| 24 |
[GO] |
2022―Feb―18 |
Elevated Tacrolimus Levels at Time of Diagnosis of COVID-19 Compared to Baseline Among Hospitalized Organ Transplant Recipients |
Krista Mecadon, Anna Hardesty, Kendra Vieira, Ralph Rogers, Basma Merhi, Adena J. Osband, et al. (+5) George Bayliss, MD, Reginald Gohh, Paul Morrissey, Dimitrios Farmakiotis |
| 25 |
[GO] |
2022―Feb―08 |
COVID-19 Vaccine-Associated Pericarditis |
Giuseppe Famularo, Maria Cristina Macciomei |
| 26 |
[GO] |
2022―Jan―13 |
Evaluation of the Clinical Impact of Thromboprophylaxis in Patients With COVID-19 Following Hospital Discharge |
Lindsay A. Courtney, Toby C. Trujillo, Joseph J. Saseen, Garth Wright, Surabhi Palkimas |
| 27 |
[GO] |
2022―Jan―13 |
Medication Changes and Diagnosis of New Chronic Illnesses in COVID-19 Intensive Care Unit Survivors |
Rima A. Mohammad, Cynthia T. Nguyen, Patrick G. Costello, Janelle O. Poyant, Siu Yan Amy Yeung, Kaitlin Landolf, et al. (+6) Andy Kim, Katherine L. Artman, Dakota C. Taylor, Michael T. Kenes, Tuqa Alkhateeb, Joanna L. Stollings |
| 28 |
[GO] |
2022―Jan―13 |
Evaluation of Continuous Inhaled Epoprostenol in the Treatment of Acute Respiratory Distress Syndrome, Including Patients With SARS-CoV-2 Infection |
Hannah L. Niss, Adham Mohamed, Timothy P. Berry, Timothy M. Saettele, Michelle M. Haines, Elizabeth L. Thomas |
| 29 |
[GO] |
2022―Jan―11 |
Finally, an FDA Approval for an Immunization Against COVID-19: Hope on the Horizon |
Jason Powell, Christopher R. Piszczatoski |
| 30 |
[GO] |
2021―Sep―09 |
Comment: The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019 |
Ju-Tae Sohn |
| 31 |
[GO] |
2021―Sep―06 |
Reply: The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019 |
Corey J. Witenko, Audrey J. Littlefield, Sajjad Abedian, Anjile An, Philip S. Barie, Karen Berger |
| 32 |
[GO] |
2021―Sep―02 |
Hypertriglyceridemia in Critically Ill Patients With SARS-CoV-2 Infection |
Wasim S. El Nekidy, Abdullah Shatnawei, Manal M. Abdelsalam, Mariam Hassan, Ruba Z. Dajani, Nouran Salem, et al. (+4) Terrence J. Lee St. John, Nadeem Rahman, Fadi Hamed, Jihad Mallat |
| 33 |
[GO] |
2021―Jul―31 |
Comment: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk |
Brittany D. Bissell, Breanne Mefford, J. Chris Donaldson |
| 34 |
[GO] |
2021―Jul―31 |
Reply: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk |
Xian Jie Cindy Chen, Diana Altshuler, Peter Spiegler, Shari B. Brosnahan |
| 35 |
[GO] |
2021―Jul―29 |
Evaluation of Bivalirudin as the Primary Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation for SARS-CoV-2-Associated Acute Respiratory Failure |
Brittany D. Bissell, Taylor Gabbard, Erica A. Sheridan, Maher A. Baz, George A. Davis, Ayesha Ather |
| 36 |
[GO] |
2021―Jun―28 |
Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk |
Shari B. Brosnahan, Xian Jie Cindy Chen, Juri Chung, Diana Altshuler, Shahidul Islam, Sarun V. Thomas, et al. (+6) Megan D. Winner, Allison A. Greco, Jasmin Divers, Peter Spiegler, Daniel H. Sterman, Sam Parnia |
| 37 |
[GO] |
2021―Jun―23 |
Interventions in an Ambulatory Setting to Prevent Progression to Severe Disease in Patients With COVID-19: A Systematic Review |
Eamon O Murchu, Susan Spillane, Paula Byrne, Michelle O’Neill, Patricia Harrington, Máirín Ryan |
| 38 |
[GO] |
2021―Jun―02 |
Sedation Usage in COVID-19 Acute Respiratory Distress Syndrome: A Multicenter Study |
Natalie Tapaskar, Daniel Colon Hidalgo, Grace Koo, Krupa Shingada, Swathi Rao, Raul Rodriguez, et al. (+9) Daniel Alcantar, Diana Espinoza Barrera, Raymond Lee, Naveen Rameshkumar, Mukarram Amine, Shelden Rodrigues, Fanny Giron, Akshata Chaugule, Megan A. Rech |
| 39 |
[GO] |
2021―Mai―14 |
The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019 |
Corey J. Witenko, Audrey J. Littlefield, Sajjad Abedian, Anjile An, Philip S. Barie, Karen Berger |
| 40 |
[GO] |
2021―Apr―22 |
Approach to Sedation and Analgesia in COVID-19 Patients on Venovenous Extracorporeal Membrane Oxygenation |
Diane Dreucean, Jesse E. Harris, Prakruthi Voore, Kevin R. Donahue |
| 41 |
[GO] |
2021―Mrz―04 |
Mechanisms and Potential Roles of Glucose-Lowering Agents in COVID-19: A Review |
Helen D. Berlie, Pramodini B. Kale-Pradhan, Tara Orzechowski, Linda A. Jaber |
| 42 |
[GO] |
2020―Dez―11 |
Hydroxychloroquine-Induced Premature Ventricular Contractions in a Patient With COVID-19 Disease |
Dhouha Sahnoun, Maha Abid, Neila Fathallah, Foued Belazreg, Chaker Ben Salem |
| 43 |
[GO] |
2020―Mai―27 |
CORRIGENDUM to Emergency Approval of Chloroquine and Hydroxychloroquine for Treatment of COVID-19 (updated to Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19) |
|
| 44 |
[GO] |
2020―Mai―12 |
Myth Busters: Dietary Supplements and COVID-19 |
Kathleen K. Adams, William L. Baker, Diana M. Sobieraj |
| 45 |
[GO] |
2020―Mai―09 |
Emergency Approval of Chloroquine and Hydroxychloroquine for Treatment of COVID-19 |
Christopher R. Piszczatoski, Jason Powell |
